Rezultati pretraživanja
  1. Odgovor korisniku/ci

    legalized commercialized ... V ... illegal free ? .

  2. prije 25 minuta

    Azelis India acquires S Zhaveri Pharmakem distribution business |

  3. prije 2 sata

    The global generics industry is so massive it now throws its weigh around like brand-name big . Regulators must put quality and data transparency before IP compliance. Let Leena Meghaney explain:

  4. Use your Time smart. Feelings are data and Leadership is a passion a desire to use your data for better

  5. prije 2 sata

    Syneos Health Commercial Solutions: Key Account Manager - Respiratory - South…

  6. prije 2 sata

    Covance: Inside Sales Manager I

  7. prije 3 sata
  8. prije 3 sata

    PRA Health Sciences: Clinical Project Manager

  9. Try our e-Pharma Software 1.Increase your revenues and profits 2.Increase Brand Reputation 3.Optimize Productivity 4.Increase Visibility For further information contact us: ☎️ +971 4 268 1410 📧 midlandsolutions@e-wf.ae #pharmacysoftware#eworkforce

  10. PN Update: Progress-EXS to highlight Lean Six Sigma service at Innovations for Health 2020

  11. prije 6 sati

    The U.S. pharmaceutical giant is partnering with Insilico Medicine, a drug discovery engine and data analytics company on a new and potentially larger mission to help it turn its AI tools for drug design and target identification 🔬

  12. bouncing from trendline support

  13. prije 12 sati
  14. prije 18 sati

    Drug rep regrets Handi-Caps. Doc Rat golden oldie DR1211

  15. 31. sij

    Drug rep makes a patent admission. Doc Rat golden oldie DR1210

  16. Odgovor korisniku/ci

    Until the CEOs themselves see long jail times, fines hardly affect the cos. They make mega billions, and the 100 millions in fines are peanuts. It's a sad game played by govt & pharma, pretending there's justice & accountability. In the end, continues to go its merry way.

  17. 30. sij

    Drug rep has exciting news. Doc Rat golden oldie DR1209

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.